Mannose modified co-loaded zoledronic liposomes deplete M2-tumor-associated macrophages to enhance anti-tumor effect of doxorubicin on TNBC-Reference-Cited by-同舟云学术

Mannose modified co-loaded zoledronic liposomes deplete M2-tumor-associated macrophages to enhance anti-tumor effect of doxorubicin on TNBC

Published:2022-08 Issue: Volume:74 Page:103551
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Wendong Yao,Hengwu Xu,Yanhong Chen,Yingying Xu,Feng Zhou,Zeng Wang,Xinjun Cai

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference44 articles.

1. Targeting Immune Pathways in Breast Cancer: Review of the Prognostic Utility of TILs in Early Stage Triple Negative Breast Cancer (TNBC);Blackley,2019

2. Inhibition of breast cancer cell migration by activation of cAMP signaling;Dong;Breast Cancer Res. Treat.,2015

3. Adjuvant addition of capecitabine to early-stage triple-negative breast cancer patients receiving standard chemotherapy: a meta-analysis;Li;Breast Cancer Res. Treat.,2020

4. Phase I/II trial of combined pegylated liposomal doxorubicin and cyclophosphamide in metastatic breast cancer;Chang;Clin. Breast Cancer,2018

5. Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity;Tang;Drug Deliv.,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective γδ T‐cell clinical therapies: current limitations and future perspectives for cancer immunotherapy;Clinical & Translational Immunology;2024-01

2. Anti-oxidative and anti-aging effects of mannoprotein-rich yeast cell wall enzymatic hydrolysate by modulating gut microbiota and metabolites in Caenorhabditis elegans;Food Research International;2023-08